title: Attacking MALT1 for ABC-DLBCL therapy.
authors: Daniel
authors: D
authors: Krappmann
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001402:B-Lymphocytes / Q000187:drug effects* / Q000201:enzymology / Q000276:immunology; D061945:Caspase Inhibitors / Q000627:therapeutic use*; D020169:Caspases / Q000235:genetics / Q000378:metabolism; D015195:Drug Design; D006801:Humans; D008213:Lymphocyte Activation / Q000187:drug effects*; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy* / Q000201:enzymology / Q000235:genetics / Q000276:immunology; D058990:Molecular Targeted Therapy; D000074884:Mucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 Protein; D009363:Neoplasm Proteins / Q000037:antagonists & inhibitors* / Q000235:genetics / Q000378:metabolism; D015398:Signal Transduction / Q000187:drug effects
chemical_list: D000970:Antineoplastic Agents; D061945:Caspase Inhibitors; D009363:Neoplasm Proteins; D020169:Caspases; C400109:MALT1 protein, human; D000074884:Mucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 Protein